Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
But a surprising number of them are quietly leaving results on the table because of one overlooked variable: protein intake that sounds high but functionally isn't
Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis Glucagon-like peptide-1 receptor (GLP-1R) agonists used to treat type 2 diabetes mellitus often produce nausea, vomiting, and in some patients, undesired anorexia
What is wrong with this picture
While no food destroys GLP-1, certain foods can impair its effectiveness, such as: Refined sugars and simple carbohydrates Ultra-low-fiber diets Skipping protein regularly These foods can disrupt blood sugar, gut health and hormonal signaling
almond butter to the apple at lunch and add cup unsalted dry-roasted almonds as an evening snack
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
